New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors

Author: Chan-Hee JUNG ¹
Author Information

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
Publication Type:Editorial
From:Endocrinology and Metabolism 2021;36(2):339-341
CountryRepublic of Korea
Language:English